EFTUD2 and hepatocellular carcinoma: Notably, we detected high expression of wild-type EFTUD2 in this patient, consistent with its reported oncogenic role in hepatocellular carcinoma (Tu et al., 2020), and suggesting that EFTUD2 may also contribute to leukemogenesis in ALL.